Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis

References

• WHO 2004. http://www.who.int/mentalhealth/neurology/en (accessed 10 August 2005)
   Google Scholar
• National Multiple Sclerosis Society (NMSS). Research Briefs. National Multiple Sclerosis Society, New York 2002
   Google Scholar
• National Multiple Sclerosis Society (NMSS). Epidemiology of Multiple sclerosis. 2004. www.nationalmssociety.org/Sourcebook-epidemiology.asp. (accessed 20 August 2005)
   Google Scholar
• Finlayson M, Denend T V, Hudson E. Aging with Multiple sclerosis. J Neurosci Nurs 2004; 36(5)245–251
   PubMedGoogle Scholar
• Russo P, Cappone A, Paolillo A, Macchia F, et al. Cost analysis of relapsing remitting multiple sclerosis in Italy after introduction of new disease modifying agents. Clin Drug Invest 2004; 24(7)409–420
   PubMed Web of Science ®Google Scholar
• Multiple sclerosis: Management of multiple sclerosis in primary and secondary care. Clinical Guidelines – 8. November 2003. National Institute for Clinical Excellence (NHS). ISBN: 1842574426 [www.nice.org.uk] (accessed 20 August 2005)
   Google Scholar
• Ewert T, Fuessl M, Cieza A, Anderson C, et al. Identification of the most common patient problems in patients with chronic conditions using the ICF checklist. J Rehabil Med 2004, Suppl 44: 22–29
   PubMed Web of Science ®Google Scholar
• WHO. International Classification of Functioning, Disability and Health: ICF. WHO, Geneva 2001
   Google Scholar
• Stucki G, Ewert T, Cieza A. Value and application of theICF in rehabilitation medicine. Disabil Rehabil 2002; 24(17)932–938
   PubMed Web of Science ®Google Scholar
• Ustin T B, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The World Health Classification, ICIDH-2 Checklist version 2.1a, clinical form for international classification of Functioning, Disability and Health: ICF. WHO, Geneva 2001
   Google Scholar
• Geyh S, Alarcos C, Schouten J, Dickson H, et al. ICF core sets for Stroke. J Rehabil Med 2004, Suppl 44: 135–141
   PubMed Web of Science ®Google Scholar
• Cieza A, Brockow T, Ewet T, Amman E, et al. Linking health status measurements to the International Classification of Functioning, Disability and Health. J Rehabil Med 2002; 34: 205–210
   PubMed Web of Science ®Google Scholar
• Cieza A, Ewert T, Ustun B, Chatterji S, et al. Development of ICF core sets for patients with chronic conditions. J Rehabil Med 2004, Suppl 44: 9–14
   PubMed Web of Science ®Google Scholar
• Grill E, Ewert T, Chatterji S, Kostanjsek N, et al. ICF core sets development for the acute hospital and early post – acute rehabilitation facilities. Disabil Rehabil 2005; 27(7/8)361–366
   PubMed Web of Science ®Google Scholar
• Grill E, Huber E O, Stucki G, Herceg M, et al. identification of relevant ICF caregories by patients in the acute hospital. Disabil Rehabil 2005; 27(7/8)447–458
   PubMed Web of Science ®Google Scholar
• Grill E, Lipp B, Boltd C, Stucki G, et al. Identification of relevant ICF categories by patients with neurological conditions in early post acute rehabilitation facilities. Disabil Rehabil 2005; 27(7/8)459–465
   PubMed Web of Science ®Google Scholar
• Grill E, Stucki G, Boltd C, Joisten C, et al. Identification of relevant ICF categories by geriatric patients in an early post acute rehabilitation facility. Disabil Rehabil 2005; 27(7/8)467–473
   PubMed Web of Science ®Google Scholar
• Khan F, McPhail T, Brand C, Turner-Stokes L, Kilpatrick T. Multiple sclerosis: Disability profile and quality of life in an Australian community cohort. Int J Rehabil Res 2006; 29(2), 87 – 96
   Web of Science ®Google Scholar
• Dombovy M L. Multiple sclerosis and Parkinsons disease rehabilitation. Principles of neurological rehabilitation, R Lazar. McGraw-Hill, New York 1998; 173–197
   Google Scholar
• Kraft G H, Caranzaro M L. Living with multiple sclerosis: A wellness approach. Demos, New York 1996
   Google Scholar
• Nortvedt M W, Riise T, Landtblom A M, Bakke A, et al. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis 2001; 7: 231–235
   PubMed Web of Science ®Google Scholar
• Borello-France D, Leng W, O'Leary M, Xavier M, et al. Bladder and sexual function among women with multiple sclerosis. Multiple Sclerosis. 2004; 10: 455–461
   Google Scholar
• ICF literature review on environmental factors (May 2000) [www3.who.int/icf/icftemplate.cfm] (accessed 30 August 2005)
   Google Scholar
• Rice G PA, Incorvaia B, Munari L, Ebers G, et al. Interferon in relapsing remitting multiple sclerosis. J Wiley & Sons Ltd, Chichester, UK 2005, Cochrane Library, issue 2
   Google Scholar
• Creedon S D, Dijkers M P, Hinderer S R. Intrathecal Baclofen for severe spasticity: A meta analysis. Int J Rehabil Health 1997; 3(3)171–185
   Google Scholar
• Shakespeare D T, Boggild M, Young C. Antispasticity agents for multiple sclerosis, The Cochrane database of systematic reviews 2003, issue 4. Art no: CD001332. DOI: 10.1002/14651858. CD001332
   Google Scholar
• Hay Smith J, Herbison P, Ellis G, Moore K. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults, The Cochrane Database of Systematic Reviews. 2002, issue 3. Art no: CD003781. DOI: 10.1002/14651858. CD003781
   Google Scholar
• Li L, Moore D. Acceptance of disability and its correlates. J Soc Psychol 1998; 138: 13–25
   PubMed Web of Science ®Google Scholar
• Randolph J J, Arnett P A. Depression and fatigue in relapsing remitting MS: The role of symptomatic variability. Multiple Sclerosis 2005; 11: 186–190
   PubMed Web of Science ®Google Scholar
• Kroencke D C, Lynch S G, Denny D R. Fatigue in multiple sclerosis: Relationship to depression, disability and disease pattern. Multiple Sclerosis 2000; 6: 131–136
   PubMed Web of Science ®Google Scholar
• Parmenter B A, Denny D R, Lynch S G. The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Multiple Sclerosis 2003; 9: 111–118
   PubMed Web of Science ®Google Scholar
• Patten S, Metz L M, Reimer M A. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Multiple Sclerosis 2000; 6: 115–120
   PubMed Web of Science ®Google Scholar
• Romani A, Bergamaschi R, Candeloro E, Alfonsi E, et al. Fatigue in multiple sclerosis: Multidimensional assessment and response to symptomatic treatment. Multiple Sclerosis 2004; 10: 462–468
   PubMed Web of Science ®Google Scholar
• Sullivan C S, Wilken J A, Rabin B M, Demorest M, et al. Psychosocial adjustment to multiple sclerosis. International J MS Care 2004; 6: 98–105
   Google Scholar
• Mohr D C, Goodkin D E, Nelson S, Drernat D, Cox D, et al. Moderating effects on the relationship between stress and development of new brain lesions in multiple sclerosis. Psychosomatic Med 2002; 64: 803–809
   PubMed Web of Science ®Google Scholar
• Rigby S A, Domenech C, Thornton E W, Tedman S, et al. Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-Efficacy Scale. Multiple Sclerosis 2003; 9(1)73–81
   PubMed Web of Science ®Google Scholar
• Williams R M, Turner A P, Hatzakis M, Bowen J D, et al. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology 2005; 64: 75–80
   PubMed Web of Science ®Google Scholar
• Scheuringer M, Grill E, Boldt C, Mittrach R, et al. Systematic review of measures and their concepts used in published studies focusing on rehabilitation in the acute hospital and in early post acute rehabilitation facilities. Disabil Rehabil 2005; 27(7/8)419–429
   PubMed Web of Science ®Google Scholar